In metastatic colorectal cancer (mCRC), KRAS proto-oncogene, GTPase (KRAS) mutation is responsible for primary resistance to EGFR blockage [6,7,8,9]. The gene discussed is KRAS; the disease is metastatic colorectal cancer.